Watch todays video & subscribe to our monthly newsletter for news, special offers, events, and more
Same number on the syringe, completely different clinical realities
Semaglutide, also known by the brand names Wegovy and Ozempic, is a glucagon-like peptide-1 (GLP-1) receptor agonist used to lower blood sugar levels, weight loss, and to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart disease
Balestrieri ML, Rizzo MR, Barbieri M, Paolisso P, DOnofrio N, Giovane A, et al
To view or add a comment, sign in Breakthrough diabetes treatment reduces cardiovascular risks and enhances patient care Research from Swansea University highlights the vital role of semaglutide in managing type 2 diabetes and reducing cardiovascular risks